Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vanda Pharmaceuticals (VNDA) Inventory Average (2016 - 2025)

Historic Inventory Average for Vanda Pharmaceuticals (VNDA) over the last 15 years, with Q3 2025 value amounting to $10.2 million.

  • Vanda Pharmaceuticals' Inventory Average rose 702.03% to $10.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.2 million, marking a year-over-year increase of 702.03%. This contributed to the annual value of $9.9 million for FY2024, which is 911.27% down from last year.
  • Latest data reveals that Vanda Pharmaceuticals reported Inventory Average of $10.2 million as of Q3 2025, which was up 702.03% from $10.3 million recorded in Q2 2025.
  • In the past 5 years, Vanda Pharmaceuticals' Inventory Average ranged from a high of $11.3 million in Q4 2022 and a low of $6.3 million during Q1 2021
  • For the 5-year period, Vanda Pharmaceuticals' Inventory Average averaged around $9.5 million, with its median value being $9.9 million (2025).
  • In the last 5 years, Vanda Pharmaceuticals' Inventory Average soared by 7911.42% in 2021 and then tumbled by 930.94% in 2023.
  • Vanda Pharmaceuticals' Inventory Average (Quarter) stood at $8.2 million in 2021, then soared by 37.19% to $11.3 million in 2022, then fell by 9.31% to $10.2 million in 2023, then decreased by 6.83% to $9.5 million in 2024, then increased by 7.07% to $10.2 million in 2025.
  • Its Inventory Average stands at $10.2 million for Q3 2025, versus $10.3 million for Q2 2025 and $9.9 million for Q1 2025.